(CNN)President Donald Trump sought to lay blame on the Obama administration for slowing down new diagnostic testing, but a Republican senator's office and a lab association said this is not correct.
"The Obama administration made a decision on testing that turned out to be very detrimental to what we're doing," Trump said Wednesday during on a meeting addressing the coronavirus outbreak. "And we undid that decision a few days ago so that the testing can take place in a much more rapid and accurate fashion."
An aide to Sen. Lamar Alexander, R-Tennessee, said the Obama administration made no such rule change. The aide, Taylor Haulsee, said the Obama administration did propose that the Food and Drug Administration have more oversight over approving diagnostic tests, but that did not go through.
"There has not yet been significant regulatory reform of diagnostics passed by Congress," Haulsee said.
Alexander served as chairman of the Senate Committee on Health, Education, Labor and Pensions while those changes were being considered during the Obama administration.
close dialog
Sign up for CNN's
Meanwhile In America
A daily analysis of US politics for global readers.
Sign Me Up
No Thanks
By subscribing, you agree to our
privacy policy.
Sign up for CNN's
Meanwhile In America
A daily analysis of US politics for global readers.
Please enter above
Sign Me Up
No Thanks
By subscribing, you agree to our
privacy policy.
You're on the list for CNN's
Meanwhile In America
A daily analysis of US politics for global readers.
close dialog
A policy expert at the Association of Public Health Laboratories agreed with Haulsee's assessment.
When asked about Trump's remarks, Peter Kyriacopolous, chief policy officer at the association, said: "We aren't sure what rule is being referenced."
He added that "there was an intense interest from FDA to pursue regulation of lab-developed tests during the Obama administration, but it never occurred. FDA did a lot of work on this, but there never was a final rule that came out of all that work."
The White House did not offer a comment when asked to explain why the President said it was an Obama-era decision.
A policy expert at the Association of Public Health Laboratories agreed with Haulsee's assessment.
When asked about Trump's remarks, Peter Kyriacopolous, chief policy officer at the association, said: "We aren't sure what rule is being referenced."
He added that "there was an intense interest from FDA to pursue regulation of lab-developed tests during the Obama administration, but it never occurred. FDA did a lot of work on this, but there never was a final rule that came out of all that work."
The White House did not offer a comment when asked to explain why the President said it was an Obama-era decision.